This study analysed the predictive value of CEA, CA153, and HE4 combined with various immune inflammatory indicators (including Mon, Lym, Neu, Plt, NLR, and SII) in the prognosis of breast cancer. Here, CEACAM5 is linked to breast carcinoma.